Hair loss breakthrough? new Under-the-Tongue pill tested in 142 men

NCT ID NCT06924632

Completed Disease control Sponsor: Samson Clinical Operations Pty Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new way to take minoxidil for male pattern baldness: a tablet placed under the tongue. 142 men with moderate to severe hair loss took either the minoxidil tablet or a placebo twice daily for 24 weeks. The goal was to see if this method increases hair count and is safe.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: minoxidil sublingual tablet
What this could lead to: If it works, this could offer a new, easy-to-take option for men with hair loss that may be more effective than current treatments.
What could go wrong: This is a completed Phase 3 trial with 142 men, but results are not yet published. The new sublingual form may not work better than existing minoxidil or could have side effects like dizziness or heart issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

alopecia androgenetic alopecia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ANDROGENETIC ALOPECIA MALE PATTERN BALDNESS

Contacts and locations

Locations

DIRECT

East Melbourne, Victoria, 3002, Australia
DIRECT

Pascoe Vale, Victoria, 3044, Australia
Premier Specialists Pty Ltd

Kogarah, New South Wales, 2217, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.